All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

137

Reset

137 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • GFS202APhase 21 trial

    Genfleet Therapeutics (Shanghai) Inc. · Pancreatic Cancer

  • GI-108Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)

  • GTAEXS617REC-617Phase 21 trial

    Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)

  • HCW9218Phase 21 trial

    ImmunityBio, Inc. · Advanced Pancreatic Carcinoma

  • HRS-717Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer

  • HRS-7172Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer

  • HY-0102Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer

  • INV-8989Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC

  • IPN01194Phase 21 trial

    Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma

  • IvaltinostatPhase 21 trial

    CG Pharmaceuticals, Inc · Metastatic Pancreatic Adenocarcinoma

  • JMT203Phase 21 trial

    Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia

  • JYP0015Phase 21 trial

    Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)

  • KN713Phase 21 trial

    New Cancer Cure-Bio Co.,Ltd. · Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • LP-184Phase 21 trial

    Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM

  • LUM015Phase 21 trial

    Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer

  • MR001Phase 21 trial

    Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC)

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • narmafotinibPhase 21 trial

    Amplia Therapeutics Limited · Pancreatic Cancer Metastatic

  • NHS7108Phase 21 trial

    Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality

  • NUV-1511Phase 21 trial

    Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • PBP1510Phase 21 trial

    Prestige Biopharma Limited · Pancreatic Cancer

  • PEGPH20Phase 21 trial

    Roche (Genentech) · Pancreatic Adenocarcinoma

  • PepinemabPhase 21 trial

    Vaccinex Inc. · Metastatic Pancreatic Adenocarcinoma

  • RO6874281Phase 21 trial

    Roche (Genentech) · Pancreatic Adenocarcinoma

  • RP-001Phase 21 trial

    Recurv Pharma Inc · Advanced Malignancies, Oncology, Colorectal Cancer

  • RR001Phase 21 trial

    EIR Biotherapies s.r.l. · Locally Advanced Pancreatic Adenocarcinoma

  • SNS-101anti-VISTAPhase 21 trial

    Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer

  • SYS6062Phase 21 trial

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)

  • VB15010Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast

  • VMD-928Phase 21 trial

    VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer

  • vopimetostatPhase 21 trial

    Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC

  • WEF-001Phase 21 trial

    Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer

  • XER-001Phase 21 trial

    Xerient Pharma · Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Ductal Adenocarcinoma

  • XYA02Phase 21 trial

    XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer

  • Y101DPhase 21 trial

    Wuhan YZY Biopharma Co., Ltd. · Advanced Pancreatic Adenocarcinoma

  • YL-13027Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer

NewerPage 3 of 3

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.